Pfizer-Allergan deal draws criticism as USA tax dodge
A $160 billion deal announced Monday to merge Pfizer and Allergan and create the world’s biggest drug company renewed the outcry in Washington over “inversions”, in which US corporations combine with companies overseas to lower their tax bill.
Posted On Dec 06 2015